Find furosemide

Ciphergen Reports Biomarkers of Alzheimers disease

Ciphergen Biosystems, Inc. (Nasdaq: cipher) today announced the results of a multi-site studies in the discovery and validation of biomarkers for Alzheimers disease. For the discovery of biomarkers, were cerebrospinal fluid (CSF) samples examined from 65 patients with Alzheimers disease and 44 controls.


Input your comment:
Name:
Site url: http://
Message:
Enter today's date, 2 digits
(spam protection):